BMRN vs ZNTL · P/E 40, rev $1.76B vs $257.7M cap
Biomarin Pharmaceutical Inc (BMRN) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the BMRN and ZNTL stock pages for the full models.
Not investment advice.